BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16
39 results:

  • 1. CT radiomics to differentiate between Wilms tumor and clear cell sarcoma of the kidney in children.
    Deng Y; Wang H; He L
    BMC Med Imaging; 2024 Jan; 24(1):13. PubMed ID: 38182986
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to "False" Decreases in Renal Function.
    Chen MF; Harada G; Liu D; DeMatteo R; Falcon C; Wilhelm C; Kris MG; Drilon A; Gutgarts V
    J Thorac Oncol; 2024 Jan; 19(1):153-159. PubMed ID: 37748692
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes.
    Yang L; Wang X; Liu J; Liu X; Li S; Zheng F; Dong Q; Xu S; Xiong J; Fu B
    Front Immunol; 2023; 14():1225023. PubMed ID: 37638005
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A deep learning-based interpretable decision tool for predicting high risk of chemotherapy-induced nausea and vomiting in cancer patients prescribed highly emetogenic chemotherapy.
    Zhang J; Cui X; Yang C; Zhong D; Sun Y; Yue X; Lan G; Zhang L; Lu L; Yuan H
    Cancer Med; 2023 Sep; 12(17):18306-18316. PubMed ID: 37609808
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time.
    Cignoli D; Basile G; Fallara G; Rosiello G; Belladelli F; Cei F; Musso G; Re C; Bertini R; Karakiewicz P; Mottrie A; Dehò F; Gallina A; Montorsi F; Salonia A; Capitanio U; Larcher A
    BJU Int; 2023 Sep; 132(3):283-290. PubMed ID: 36932928
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Cerrato C; Patel D; Autorino R; Simone G; Yang B; Uzzo R; Porpiglia F; Capitanio U; Porter J; Beksac AT; Minervini A; Antonelli A; Cerruto MA; Lau C; Ashrafi A; Eun D; Mottrie A; Mir C; Meagher MF; Puri D; Nguyen M; Dhanji S; Liu F; Pandolfo SD; Kutikov A; Montorsi F; Gill IS; Sundaram C; Kaouk J; Derweesh IH
    World J Urol; 2023 Mar; 41(3):747-755. PubMed ID: 36856832
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.
    Zheng J; Li S; Zhao Y; Tao Z; Li L; Li Z; Li M; Chen X
    BMJ Open; 2022 Sep; 12(9):e062129. PubMed ID: 36581979
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Volumetric Quantitative Contrast-enhanced Ultrasonography Evaluation of Complex Renal Cysts: An Adjunctive Metric to the Bosniak Classification System to Predict Malignancy.
    Chandrasekar T; Clark CB; Gomella A; Wessner CE; Wang S; Nam K; Liu JB; Forsberg F; Lyshchik A; Halpern E; Mark JR; Lallas CD; Gomella LG; Kania L; Trabulsi EJ; Eisenbrey JR
    Eur Urol Focus; 2023 Mar; 9(2):336-344. PubMed ID: 36319560
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
    McGregor B; Geynisman DM; Burotto M; Porta C; Suarez C; Bourlon MT; Del Tejo V; Du EX; Yang X; Sendhil SR; Betts KA; Huo S
    Oncologist; 2023 Jan; 28(1):72-79. PubMed ID: 36124890
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States.
    Liao W; Lei W; Feng M; Yang Y; Wu Q; Zhou K; Bai L; Wen F; Li Q
    Adv Ther; 2021 Dec; 38(12):5662-5670. PubMed ID: 34664194
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Patients' radiation dose in computed tomography-fluoroscopy-guided percutaneous cryoablation for small renal tumors.
    Fukushima Y; Nakamura J; Seki Y; Ando M; Miyazaki M; Tsushima Y
    Eur J Radiol; 2021 Nov; 144():109972. PubMed ID: 34619620
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.
    Zhou X; Fu G; Zu X; Xu Z; Li HT; D'souza A; Tulpule V; Quinn DI; Bhowmick NA; Weisenberger DJ; Liang G; Chen J
    Urol Oncol; 2022 Jan; 40(1):12.e13-12.e22. PubMed ID: 34454823
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A population-based study to predict distant metastasis in patients with renal cell carcinoma.
    Li Y; Chen P; Chen Z
    Ann Palliat Med; 2021 Apr; 10(4):4273-4288. PubMed ID: 33832288
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Gene Signature of Survival Prediction for kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diabetes is associated with a higher risk of mortality among women in a middle-income country: Results form the Mexican Teacher's cohort study.
    Lozano-Esparza S; López-Ridaura R; Ortiz-Panozo E; González-Villalpando C; Aguilar-Salinas C; Hernández-Ávila JE; Hernández-Ávila M; Lajous M
    Diabetes Metab; 2020 Sep; 46(4):304-310. PubMed ID: 31525457
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.
    Bracarda S; Bamias A; Casper J; Negrier S; Sella A; Staehler M; Tarazi J; Felici A; Rosbrook B; Jardinaud-Lopez M; Escudier B
    Clin Genitourin Cancer; 2019 Jun; 17(3):e689-e703. PubMed ID: 31072748
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Red cell distribution width associations with clinical outcomes: A population-based cohort study.
    Tonelli M; Wiebe N; James MT; Naugler C; Manns BJ; Klarenbach SW; Hemmelgarn BR
    PLoS One; 2019; 14(3):e0212374. PubMed ID: 30865651
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.
    Purysko AS; Magi-Galluzzi C; Mian OY; Sittenfeld S; Davicioni E; du Plessis M; Buerki C; Bullen J; Li L; Madabhushi A; Stephenson A; Klein EA
    Eur Radiol; 2019 Sep; 29(9):4861-4870. PubMed ID: 30847589
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Time to initial cancer treatment in the United States and association with survival over time: An observational study.
    Khorana AA; Tullio K; Elson P; Pennell NA; Grobmyer SR; Kalady MF; Raymond D; Abraham J; Klein EA; Walsh RM; Monteleone EE; Wei W; Hobbs B; Bolwell BJ
    PLoS One; 2019; 14(3):e0213209. PubMed ID: 30822350
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Magnetic resonance imaging findings and differential diagnosis of renal epithelioid angiomyolipoma comparing with renal no-epithelioid angiomyolipoma].
    Guo R; Kang SH; Zhong Y; Guo AT; Wang HY; Ye HY
    Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(45):3701-3704. PubMed ID: 30526783
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2.